High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis
2007

High Expression of FcγRIIb in Rheumatoid Arthritis

Sample size: 26 publication Evidence: moderate

Author Information

Author(s): Magnusson Sofia E, Engström Marianne, Jacob Uwe, Ulfgren Ann-Kristin, Kleinau Sandra

Primary Institution: Uppsala University

Hypothesis

The study investigates the role of the inhibitory FcγRIIb in regulating synovial inflammation in rheumatoid arthritis (RA).

Conclusion

The study found that FcγRIIb is significantly expressed in RA synovium, suggesting its role in counteracting the effects of activating FcγRs.

Supporting Evidence

  • FcγRIIb was abundantly expressed in RA synovia compared to healthy synovia.
  • All activating FcγRs were significantly up-regulated in RA regardless of disease duration.
  • Glucocorticoid treatment reduced FcγR expression in arthritic joints.

Takeaway

In rheumatoid arthritis, a special protein called FcγRIIb is found in high amounts in the joints, which helps control inflammation.

Methodology

The study analyzed synovial tissue from RA patients and healthy volunteers using immunohistochemistry to assess FcγR expression.

Participant Demographics

26 RA patients (12 men, 14 women) and 10 healthy volunteers (4 men, 6 women).

Statistical Information

P-Value

0.0104

Statistical Significance

p = 0.0104

Digital Object Identifier (DOI)

10.1186/ar2206

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication